Literature DB >> 25168828

Morphologic variants of focal segmental glomerulosclerosis and their significance.

Michael B Stokes1, Vivette D D'Agati2.   

Abstract

Focal segmental glomerulosclerosis (FSGS) comprises a group of clinical-pathologic syndromes characterized by heavy proteinuria and segmental obliteration of glomerular capillaries by extracellular matrix. FSGS lesions display morphologic heterogeneity with respect to their relationship to the glomerular vascular and tubular poles, the presence of capillary collapse, and endocapillary and extracapillary hypercellularity. A working proposal, commonly referred to as the Columbia Classification, distinguishes 5 mutually exclusive morphologic variants: collapsing, tip, cellular, perihilar, and not otherwise specified (NOS), which can be applied to primary and secondary forms of FSGS. Several studies have documented significant differences in baseline clinical characteristics and outcomes between morphologic variants of primary FSGS, supporting that this classification may provide useful prognostic information. The association of certain variants with particular secondary causes of FSGS suggests pathogenetic relevance.
Copyright © 2014 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Focal segmental glomerulosclerosis; Morphologic classification

Mesh:

Year:  2014        PMID: 25168828     DOI: 10.1053/j.ackd.2014.02.010

Source DB:  PubMed          Journal:  Adv Chronic Kidney Dis        ISSN: 1548-5595            Impact factor:   3.620


  20 in total

Review 1.  FSGS: from pathogenesis to the histological lesion.

Authors:  Andrea Angioi; Antonello Pani
Journal:  J Nephrol       Date:  2016-07-09       Impact factor: 3.902

2.  Glomerular Aging and Focal Global Glomerulosclerosis: A Podometric Perspective.

Authors:  Jeffrey B Hodgin; Markus Bitzer; Larysa Wickman; Farsad Afshinnia; Su Q Wang; Christopher O'Connor; Yan Yang; Chrysta Meadowbrooke; Mahboob Chowdhury; Masao Kikuchi; Jocelyn E Wiggins; Roger C Wiggins
Journal:  J Am Soc Nephrol       Date:  2015-06-02       Impact factor: 10.121

3.  Up-to date of glomerular disease.

Authors:  Cristiana Rollino
Journal:  J Nephrol       Date:  2016-07-02       Impact factor: 3.902

4.  Proteomic Analysis Identifies Distinct Glomerular Extracellular Matrix in Collapsing Focal Segmental Glomerulosclerosis.

Authors:  Michael L Merchant; Michelle T Barati; Dawn J Caster; Jessica L Hata; Liliane Hobeika; Susan Coventry; Michael E Brier; Daniel W Wilkey; Ming Li; Ilse M Rood; Jeroen K Deegens; Jack F Wetzels; Christopher P Larsen; Jonathan P Troost; Jeffrey B Hodgin; Laura H Mariani; Matthias Kretzler; Jon B Klein; Kenneth R McLeish
Journal:  J Am Soc Nephrol       Date:  2020-06-19       Impact factor: 10.121

Review 5.  Focal Segmental Glomerulosclerosis.

Authors:  Avi Z Rosenberg; Jeffrey B Kopp
Journal:  Clin J Am Soc Nephrol       Date:  2017-02-27       Impact factor: 8.237

6.  Kidney Biopsy Features Most Predictive of Clinical Outcomes in the Spectrum of Minimal Change Disease and Focal Segmental Glomerulosclerosis.

Authors:  Jarcy Zee; Qian Liu; Abigail R Smith; Jeffrey B Hodgin; Avi Rosenberg; Brenda W Gillespie; Lawrence B Holzman; Laura Barisoni; Laura H Mariani
Journal:  J Am Soc Nephrol       Date:  2022-05-17       Impact factor: 14.978

Review 7.  Genetic testing for kidney disease of unknown etiology.

Authors:  Thomas Hays; Emily E Groopman; Ali G Gharavi
Journal:  Kidney Int       Date:  2020-04-24       Impact factor: 10.612

8.  Collapsing glomerulopathy in a patient with mixed connective tissue disease.

Authors:  Gajapathiraju Chamarthi; William L Clapp; Saraswathi Gopal
Journal:  CEN Case Rep       Date:  2020-10-14

Review 9.  Mechanisms of Scarring in Focal Segmental Glomerulosclerosis.

Authors:  Ke Sun; Qionghong Xie; Chuan-Ming Hao
Journal:  Kidney Dis (Basel)       Date:  2021-07-02

10.  Characterization of Proteinuria in Dogue de Bordeaux Dogs, a Breed Predisposed to a Familial Glomerulonephropathy: A Retrospective Study.

Authors:  Rachel Lavoué; Catherine Trumel; Pascale M Y Smets; Jean-Pierre Braun; Luca Aresu; Sylvie Daminet; Didier Concordet; Florence Palanché; Dominique Peeters
Journal:  PLoS One       Date:  2015-07-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.